New guidelines for the treatment of neuropathic pain;Nowe wytyczne dotycza̧ce leczenia bólu neuropatycznego

Neurologia i Neurochirurgia Polska

Volumn 44, Issue 5, 2010, Pages 437-442

  Stȩpień, Adam ^a   Domzał, Teofan M ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; BOTULINUM TOXIN A; CANNABINOID; CAPSAICIN; CARBAMAZEPINE; CLOMIPRAMINE; DULOXETINE; GABAPENTIN; LAMOTRIGINE; LEVORPHANOL; LIDOCAINE; METHADONE; MORPHINE; NORTRIPTYLINE; OPIATE; OXCARBAZEPINE; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE; ANALGESIC AGENT; CANNABIDIOL; LOCAL ANESTHETIC AGENT; NARCOTIC ANALGESIC AGENT;

DIABETIC NEUROPATHY; DRUG INDICATION; EDITORIAL; EUROPE; MEDICAL SOCIETY; NEUROPATHIC PAIN; PAIN; POSTHERPETIC NEURALGIA; PRACTICE GUIDELINE; TRIGEMINUS NEURALGIA; ARTICLE; CHRONIC DISEASE; EVIDENCE BASED MEDICINE; HUMAN; NEURALGIA; POLAND; POSTOPERATIVE PAIN;

ANALGESICS; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANESTHETICS, LOCAL; CANNABIDIOL; CHRONIC DISEASE; EVIDENCE-BASED MEDICINE; HUMANS; NEURALGIA; PAIN, POSTOPERATIVE; POLAND; PRACTICE GUIDELINES AS TOPIC;

EID: 78149306908     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0028-3843(14)60133-x     Document Type: Editorial

References (36)

1. Bouhassira D., Lanteri-Minet M., Attal N. i wsp. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 2008; 136: 380-387. (Pubitemid 351680253)
2. Meyer-Rosberg K., Kvarnstrom A., Kinnman E. i wsp. Peripheral neuropathic pain - a multidimensional burden for patients. Eur J Pain 2001; 5: 379-389. (Pubitemid 34072465)
3. Finnerup N.B., Otto M., McQuay H.J. i wsp. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005; 118: 289-305. (Pubitemid 41752987)
4. Consensus guidelines: treatment planning and options. Mayo Clinic Proc 2006; 81 (supl. 4): 12-25.
5. Attal N., Cruccu G., Haanpaa M. i wsp.; EFNS Task Force. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006; 13: 1153-1169.
6. Dworkin R.H., O'Connor A.B., Backonja M. i wsp. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007; 132: 237-251.
7. Canadian Diabetes Association. Clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008; 32 (supl. A): 1-15.
8. Stȩpień A. Leczenie bólu neuropatycznego - propozycje terapeutyczne oparte na kontrolowanych badaniach klinicznych. Ból 2006; 7: 17-23.
9. Dworkin R.H., Backonja M., Rowbotham M.C. i wsp. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003; 60: 1524-1534.
10. Hempenstall K., Nurmikko T.J., Johnson R.W. i wsp. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. Public Library Sci Med 2005; 2: 628-644, e164.
11. Saarto T., Wiffen P.J. Antidepressants for neuropathic pain. Cochrane Database Syst Rev 2007; 4: CD005454.
12. Kadiroglu A.K., Sit D., Kayabasi H. i wsp. The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus. J Diabetes Complications 2008; 22: 241-245. (Pubitemid 351885487)
13. McIntyre R.S., Panjwani Z.D., Nguyen H.T. i wsp. The hepatic safety profile of duloxetine: a review. Expert Opin Drug Metab Toxicol 2008; 4: 281-285.
14. Goldstein D.J., Lu Y., Detke M.J. i wsp. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005; 116: 109-118. (Pubitemid 40828506)
15. Raskin J., Pritchett Y.L., Wang F. i wsp. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005; 6: 346-356. (Pubitemid 41727332)
16. Wernicke J.F., Pritchett Y.L., D'Souza D.N. i wsp. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006; 67: 1411-1420.
17. Raskin P., Donofrio P.D., Rosenthal N.R. i wsp. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology 2004; 63: 865-873. (Pubitemid 39297649)
18. Taylor C.P. Mechanisms of action of gabapentin. Drugs Today 1998; 34: 3-11.
19. Mellegers M.A., Furlan A.D., Milis A. Gabapentin for neuropathic pain: systemic review of controlled and uncontrolled literature. Clin J Pain 2001; 17: 284-295.
20. Moore R.A., Straube S., Wiffen P.J. i wsp. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev 2009; (3): CD007076.
21. Wiffen P.J., McQuay H.J., Rees J. i wsp. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 2005; (3): CD005452.
22. Hurley R.W., Maggie R.L., Adams M. i wsp. Pregabalin as a treatment for painful diabetic peripheral neuropathy: a meta-analysis. Reg Anesth Pain Med 2008; 33: 389-394.
23. Tassone D.M., Boyce E., Guyer J. i wsp. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders. Clin Therapeutics 2007; 29: 26-48. (Pubitemid 46415802)
24. Quilici S., Chancellor J., Lothgren M. i wsp. Meta-analysis of duloxetine vs pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain. BMC Neurol 2009; 9: 6.
25. Morello C.M., Leekband S.G., Stoner C.P. i wsp. Randomized double-blind study comparing efficacy of gabapentin with amitiptyline on diabetic peripheral neuropathy pain. Arch Intern Med 1999; 159: 1931-1937.
26. Simpson D.A. Gabapentin and venlafaxine for treatment of painful diabetic neuropathy. J Clin Neuromuscul Dis 2001; 3: 53-62. (Pubitemid 33130299)
27. Sabatowski R., Galvez R., Cherry D.A. i wsp. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomized, placebo-controlled clinical trial. Pain 2004; 109: 26-35. (Pubitemid 38479767)
28. Richter R.W., Portenoy R., Dharma U. i wsp. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo controlled trial. J Pain 2005; 6: 253-260.
29. Dworkin R.H., Corbin A.E., Young J.P. i wsp. Pregabalin for the treatment of postherpetic neuralgia. A randomized, placebo-controlled trial. Neurology 2003; 60: 1274-1283.
30. Gahimer J., Wernicke J., Yalcin I. i wsp. A retrospective pooled analysis of duloxetine safety in 23 983 subjects. Curr Med Res Opin 2007; 23: 175-184. (Pubitemid 46191681)
31. Backonja M., Glanzman R.L. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo controlled clinical trials. Clin Therapeutics 2003; 25: 81-104. (Pubitemid 36206739)
32. Freynhagen R., Strojek K., Griesing T. i wsp. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomized, double-blind, multicentre, placebo-controlled trial of flexible-and fixed-dose regiments. Pain 2005; 115: 254-263.
33. Selak I. Pregabalin (Pfizer). Curr Opin Invest Drugs 2001; 2: 828-834.
34. Foley K.M. Opioids and chronic neuropathic pain. N Engl J Med 2003; 348: 1279-1281.
35. Dellemijn P. Are opioids effective in relieving neuropathic pain? Pain 1999; 80: 453-462. (Pubitemid 29182695)
36. Gimbel J.S., Richards P., Portenoy R.K. Controlled-release oxycodone for pain in diabetic neuropathy: a randomised controlled trial. Neurology 2003; 60: 927-934. (Pubitemid 36348923)